Logo Linkedin Logo Twitter

Home

HR Excellence in Research

Previous Pause Next

Skip to Navigation ↓

Main menu

  • What is ARAID?
  • Calls
  • Researchers
  • Activities
  • Transparency
  • HR Strategy for Researchers
  • News

Activities

  • Publications
  • Congresses
  • Projects
  • PhD Thesis
  • Patents
  • R&D Organization
  • Other research activities
  • Contracts
  • Other transfer activities
  • Conferences
  • Teaching
  • Other outreach activities
  • Grants & awards
  • English
  • Español

.

Adrián Velázquez Campoy
Institute of Biocomputation and Physics of Complex Systems (BIFI) (UZ)
Instituto de Biocomputación y Física de Sistemas Complejos (BIFI) (UZ)
ARAID Senior Researcher
Education: 
PhD in Physics
Research interests: 
Biophysical study (conformational landscape, interactions and fucntion) of pharmacological targets and proteins with biotechnological and biomedical relevance by spectroscopy and calorimetry
Identification of bioactive compounds able to modulate the function of pharmacological targets and proteins with biotechnological and biomedical relevance by experimental molecular screening
Development of experimental methodologies in calorimetry (ITC and DSC) for studying biomolecular interactions na dprotein folding and stability
Competences: 
Structural stability of proteins
Protein interactions
Protein ligand identification
Analysis of complex biological interactions (cooperativity, allostery)
Facilities and techniques: 
High sensitivity biological calorimetry
Experimental molecular screening
Protocols and methodologies for studying biomolecular interactions
Keywords: 
Biophysics, Biotechnology, Protein stability and folding, Protein interactions, Calorimetry, Molecular screening, Drug discovery, Biomarkers
Links: 
ResearchGate profile
Google Scholar profile
ResearcherID profile
ORCID profile
Relevant publications: 
Thermal Liquid Biopsy for monitoring melanoma patients under surveillance during treatment: A pilot study
Identification of a drug targeting an intrinsically disordered protein involved in pancreatic adenocarcinoma
The intervening domain from MeCP2 enhances the DNA affinity of the methyl binding domain and provides an independent DNA interaction site

Legal advice - Privacy notice